Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $29.5100 (-0.37%) ($28.7500 - $30.3400) on Sun. Jun. 14, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.24% (three month average) | RSI | 19 | Latest Price | $29.5100(-0.37%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -1.2% a day on average for past five trading days. | Weekly Trend | IOVA declines -7.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting IOVA price | IOVA will decline at least -3.62% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.62% (StdDev 7.24%) | Hourly BBV | 0 () | Intraday Trend | -2.1% | | | |
|
1 - 5 Day Possible Target | $14.2(-51.88%) | Resistance Level | $33.89 | 5 Day Moving Average | $30.97(-4.71%) | 10 Day Moving Average | $31.51(-6.35%) | 20 Day Moving Average | $33.89(-12.92%) | To recent high | -28% | To recent low | 51% | Market Cap | $N/A | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |